Sanità 6 Dicembre 2016 13:19

Lung cancer: women mortality increases in Europe

The lung cancer is responsible for the huge number of deaths in France. It is mostly linked to the tobacco addiction and it is the most dangerous for men and the second one for women, with respectively 21000 and 9500 deaths. However, the Eurostat highlights a fall of death rate for men and an increase for women in Europe. Within the framework of the third Project about cancer 2014-2019, the French National High Authority for Health has the goal of detecting the cancer in smokers at an early stage, to make the treatment more effective. But the present situation shows that: the disease is hardly detected at an early stage because of its rapid evolution; the available exam is not suitable; treatment possibilities are extremely tight, also at an early stage; people who could take advantage of this exam are hardly identifiable; the mortality reduction is not assured in the French context; there are too many risks and few reliable benefits. The French National High Authority for Health concludes by saying that it is necessary to carry on the researches on the treatment, the disease characteristics and the detecting technics. It is also important to intensify the battle against the tobacco addiction with measures that increase awareness in young people and smokers to stop smoking.

GLI ARTICOLI PIU’ LETTI
Salute

Sanità Informazione sospende gli aggiornamenti per la pausa estiva

Sanità Informazione sospende gli aggiornamenti per la pausa estiva. La redazione ringrazia tutti i lettori e dà appuntamento al prossimo 25 agosto.
Sanità

Consiglio Superiore di Sanità, si è insediata la nuova squadra

La presidenza al professor Alberto Siracusano. Schillaci: "Il Consiglio Superiore di Sanità rappresenta, da sempre, un pilastro della sanità italiana e un riferimento per tutto il sistem...
Advocacy e Associazioni

Sindrome di Down, si può davvero “eliminare” il cromosoma in più?

Dopo lo studio giapponese che ha rimosso in laboratorio una copia del cromosoma 21, la Down Syndrome Task Force, CoorDown e AIPD spiegano perché non si tratta (ancora) di una cura
Advocacy e Associazioni

Malattie ultrarare, la sfida della SPG50: “L’Italia si prepara ad accogliere la prima terapia genica”

Anche l’Italia, dopo il Canada e la Spagna, si prepara ad accogliere la terapia per la SPG50, una rarissima forma di paraplegia spastica ereditaria, entro la fine dell’anno. In un’in...